This inventor holds 2 USPTO granted patents and 5 published patent applications and 4 EPO patents. Top assignee: Merz Pharma Gmbh & Co Kgaa. Active years: 2014-2016.
Company Filing History:
Years Active: 2014-2016
Title: Tanja Rosenberg: Innovator in Cochlear Tinnitus Treatment
Introduction
Tanja Rosenberg is a prominent inventor based in Hamburg, Germany. She has made significant contributions to the field of medical treatments, particularly focusing on cochlear tinnitus. With a total of 2 patents to her name, her work is paving the way for innovative solutions in healthcare.
Latest Patents
Rosenberg's latest patents include groundbreaking inventions aimed at treating cochlear tinnitus. The first patent, titled "1-amino-cyclohexane derivatives for the treatment of cochlear tinnitus," relates to administering an effective amount of a 1-amino-alkylcyclohexane derivative to individuals afflicted with this condition. The second patent, "Titration package for neramexane and its use in the treatment of an inner ear disorder," outlines a titration scheme for administering a 1-amino-alkylcyclohexane derivative. This scheme allows for the quick attainment of an effective dose while minimizing side effects, making it particularly useful in treating various diseases, including tinnitus.
Career Highlights
Tanja Rosenberg is currently associated with Merz Pharma GmbH & Co KGaA, where she continues to innovate and develop new treatments. Her work is characterized by a commitment to improving patient outcomes through scientific research and development.
Collaborations
Rosenberg collaborates with notable colleagues, including Michael Althaus and Barbara Ellers-Lenz. These partnerships enhance her research efforts and contribute to the advancement of medical treatments.
Conclusion
Tanja Rosenberg's contributions to the field of cochlear tinnitus treatment exemplify her dedication to innovation in healthcare. Her patents reflect a commitment to improving the lives of individuals affected by this condition.